EFFECT OF SODIUM-GLUCOSE CO-TRANSPORTER-2 INHIBITORS ON BIOMARKERS OF CARDIAC REMODELING: A SYSTEMATIC REVIEW AND META-ANALYSIS

被引：0
作者：
Ros, Marta Lorente
Ros, Alvaro Lorente
Romeo, Francisco Jose
Gallardo, Jose Aguilar
Mahmood, Kiran
机构：
[1] Georgetown Univ, Medstar Washington Hosp Ctr, Washington, DC USA
[2] Icahn Sch Med Mt Sinai, New York, NY USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1343-123
引用
收藏
页码：553 / 553
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of metformin and sodium-glucose co-transporter-2 inhibitors in adults with type 1 diabetes: A systematic review and network meta-analysis
    Zhang, Q.
    Wu, Y.
    Lu, Y.
    Fei, X.
    REVISTA CLINICA ESPANOLA, 2020, 220 (01): : 8 - 21
  • [22] Effect on cardiovascular outcome of sodium-glucose co-transporter-2 (SGLT2) inhibitors among patients with cancer treated with anthracycline: A systematic review and meta-analysis
    Wannaphut, Chalothorn
    Wattanachayakul, Phuuwadith
    Saowapa, Sakditad
    Ponvilawan, Ben
    Tanariyakul, Manasawee
    Kewcharoen, Jakrin
    Yingchoncharoen, Pitchaporn
    Aiumtrakul, Noppawit
    Acoba, Jared David
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [23] Sodium-glucose co-transporter-2 inhibitors with and without metformin: A meta-analysis of cardiovascular, kidney and mortality outcomes
    Neuen, Brendon L.
    Arnott, Clare
    Perkovic, Vlado
    Figtree, Gemma
    de Zeeuw, Dick
    Fulcher, Greg
    Jun, Min
    Jardine, Meg J.
    Zoungas, Sophia
    Pollock, Carol
    Mahaffey, Kenneth W.
    Neal, Bruce
    Heerspink, Hiddo J. L.
    DIABETES OBESITY & METABOLISM, 2021, 23 (02) : 382 - 390
  • [24] REPURPOSING SODIUM-GLUCOSE CO-TRANSPORTER-2 INHIBITORS FOR GEROTHERAPY
    Espinoza, Sara
    INNOVATION IN AGING, 2024, 8 : 140 - 140
  • [25] Sodium-glucose co-transporter-2 inhibitors and epicardial adiposity
    Yaribeygi, Habib
    Maleki, Mina
    Butler, Alexandra E.
    Jamialahmadi, Tannaz
    Sahebkar, Amirhossein
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 180
  • [26] Effects of sodium-glucose co-transporter 2 inhibitors on blood pressure: A systematic review and meta-analysis
    Baker, William L.
    Smyth, Lindsay R.
    Riche, Daniel M.
    Bourret, Emily M.
    Chamberlin, Kevin W.
    White, William B.
    JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2014, 8 (04) : 262 - 275
  • [27] Effect on cardiovascular outcome of sodium-glucose co-transporter-2 (SGLT2) inhibitors among cancer patients treated with anthracycline: a systematic review and meta-analysis
    Wannaphut, Chalothorn
    Wattanachayakul, Phuuwadith
    Saowapa, Sakditad
    Ponvilawan, Ben
    Tanariyakul, Manasawee
    Kewcharoen, Jakrin
    Yingchoncharoen, Pitchaporn
    Suenghataiphorn, Thanathip
    Aiumtrakul, Noppawit
    Acoba, Jared
    ECANCERMEDICALSCIENCE, 2025, 19
  • [28] Sodium-glucose co-transporter-2 inhibitors for the prevention of cardiorenal outcomes in type 2 diabetes: An updated meta-analysis
    Giugliano, Dario
    Longo, Miriam
    Caruso, Paola
    Maiorino, Maria Ida
    Bellastella, Giuseppe
    Esposito, Katherine
    DIABETES OBESITY & METABOLISM, 2021, 23 (07) : 1672 - 1676
  • [29] Fournier's gangrene and sodium-glucose co-transporter-2 inhibitors: A meta-analysis of randomized controlled trials
    Silverii, Giovanni Antonio
    Dicembrini, Ilaria
    Monami, Matteo
    Mannucci, Edoardo
    DIABETES OBESITY & METABOLISM, 2020, 22 (02) : 272 - 275
  • [30] Acute kidney injury with sodium-glucose co-transporter-2 inhibitors: A meta-analysis of cardiovascular outcome trials
    Gilbert, Richard E.
    Thorpe, Kevin E.
    DIABETES OBESITY & METABOLISM, 2019, 21 (08) : 1996 - 2000
12345